This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com

Underserved communities need better access to mental health treatments, which means we need to develop new and different ways to deliver care.

In this episode, Joseph Perekupka, CEO of Freespira, discusses the company's at-home medical device that targets PTSD and panic disorder symptoms through a non-pharmacological approach. The treatment involves a sensor, tablet, and care specialist who acts as a coach to guide patients through the 28-day program. Joe highlights the significance of visualizing breathing patterns, experiencing early action, and receiving dedicated support, with patients showing significant symptom improvements. He emphasizes that CMS's new reimbursement codes will incentivize providers to offer a more robust treatment plan. Joe also predicts a move toward action in mental health treatment in 2025, focusing on broader care access, including supporting first responders with PTSD. 

Tune in and learn about the future of digital mental healthcare and innovative solutions for anxiety and PTSD!

Fast Track Your Business Growth:

Outcomes Rocket is a full service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com